Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Baron Growth Fund Neal Rosenberg | “FIGS, Inc. designs and sells scrubwear for health care professionals through a digitally native, direct-to-consumer strategy. The stock detracted from performance as shares slipped due largely to investor positioning. Even so, the company reported a very strong first quarter. Revenue came in at $159.9 million, up 28%, well ahead of the company's guidance for low-20% growth and above consensus expectations. The results were broad-based. U.S. revenue grew 24% to $131.6 million, with strength across core offerings, new product launches, and promotional periods, while international revenue accelerated 50% to $28.3 million, with double-digit growth in every region. Active customers surpassed 3 million for the first time, up 12% year over year, with both new and repeat customers contributing. We continue to have conviction in the strength of FIGS' business model and the company's ability to gain market share in the attractive global health care apparel industry.” | NEUTRAL | Q2 2026 Aug 14, 2026 | View Pitch |
Baron Focused Growth Fund David Baron, Ron Baron | “FIGS, Inc. designs and sells scrubwear for health care professionals through a digitally native, direct-to-consumer strategy. The stock detracted from performance as shares slipped due largely to investor positioning. Even so, the company reported a very strong first quarter. Revenue came in at $159.9 million, up 28%, well ahead of the company's guidance for low-20% growth and above consensus expectations. The results were broad-based. U.S. revenue grew 24% to $131.6 million, with strength across core offerings, new product launches, and promotional periods, while international revenue accelerated 50% to $28.3 million, with double-digit growth in every region. Active customers surpassed 3 million for the first time, up 12% year over year, with both new and repeat customers contributing. We continue to have conviction in the strength of FIGS' business model and the company's ability to gain market share in the attractive global health care apparel industry.” | NEUTRAL | Q2 2026 Aug 11, 2026 | View Pitch |
Baron Focused Growth Fund David Baron, Ron Baron | “Shares of FIGS increased 69.8% in the fourth quarter and added 161 bps to performance. The company continues to generate strong results, and revenue has recently accelerated from investments made over the past year. This is despite making a conscious decision to pull back on promotions. The company is now seeing more normal purchasing and replenishment trends while also benefitting from specific initiatives around product and marketing that are resonating with its customers. FIGS is also seeing better efficiencies out of its new fulfillment center that are resulting in strong margin improvement as well. We continue to believe FIGS can take share in the attractive $80 billion global health care apparel industry. Health care remains one of the fastest growing employment industries in the U.S. and FIGS benefits from being a need-based replenishment item. The company is well positioned to take share in the industry through its premium, high-quality products. In addition, we believe FIGS will also see growth from its initiatives to grow stores, business to business revenue, and expand internationally. We believe the revenue acceleration combined with margin expansion and strong cash generation should leave the company well positioned for further growth over time. BSD Analysis: FIGS, Inc. enters 2026 as a stabilizing brand in the healthcare apparel market, focusing on expanding its "FIGS PRO" corporate program to drive more predictable, institutional revenue. The company is successfully leveraging its direct-to-consumer (DTC) model to maintain premium pricing while expanding into international markets like Europe and Australia. For 2026, the investment thesis is centered on the firm's path toward higher profitability as it optimizes its marketing spend and streamlines its logistics network. While competition from legacy brands and new entrants remains intense, FIGS' high brand loyalty and "community-first" approach provide a durable competitive advantage. Management is increasingly focused on product diversification, including footwear and outerwear, to capture a larger share of the healthcare professional's daily wardrobe. Financial results are expected to show a meaningful recovery in EBITDA margins as the company laps tough comparatives from its expansion phase. For investors, FIGS represents a high-potential "valuation reset" play in the specialized retail space.” | BULL | Q4 2025 Dec 31, 2025 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
